Regencell Bioscience Holdings (RGC) Minority Interest (2022 - 2023)
Regencell Bioscience Holdings (RGC) reported Minority Interest of -$40898.0 for Q2 2023, down 365.78% on a YoY basis from $15388.0 in Q2 2022, and down 365.78% quarter-over-quarter from $15388.0 in Q2 2022.
Regencell Bioscience Holdings (RGC) Minority Interest (2022 - 2023) Analysis & Trends
Regencell Bioscience Holdings has reported Minority Interest for 2 years, with the latest figure at -$40898.0 in Q2 2023.
- For the quarter ending Q2 2023, Minority Interest fell 365.78% year-over-year to -$40898.0; the trailing twelve-month figure through Jun 2023 stood at -$40898.0 (down 365.78% YoY), and the FY2023 full-year result was -$40898.0, down 365.78% from the prior year.
- Minority Interest for Q2 2023 stood at -$40898.0, down from $15388.0 in the prior quarter.
- The five-year high for Minority Interest was $15388.0 in Q2 2022, with the low at -$40898.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Regencell Bioscience Holdings | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -40,898.00 |
| Jun 30, 2022 | 15,388.00 |